Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Loading…
Based on limited metadata, this FDA Warning Letter issued to Ebnsol, Inc. on July 23, 2020, concerns dietary supplement products. Without access to the full letter text or subject line, the specific violations cannot be determined; however, the warning falls under FDA's dietary supplement regulatory authority. The letter likely addresses manufacturing, labeling, claims, or other compliance issues common to dietary supplement enforcement actions.